Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global lyophilized injectable drugs market 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug type trends
2.1.4 Indication trends
2.1.5 Type of delivery trends
2.1.6 Packaging trends
2.1.7 Distribution channel trends
Chapter 3 Lyophilized Injectable Drugs Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases globally
3.2.1.2 Growing research and development activities in the industry
3.2.1.3 Increasing number of product approvals for lyophilized injectable drugs
3.2.1.4 Technological advancements in lyophilized injectable drugs delivery system
3.2.2 Industry pitfalls & challenges
3.2.2.1 Substantial number of product recalls of lyophilized drugs
3.2.2.2 High costs associated with the manufacturing process
3.3 Growth potential analysis
3.3.1 By drug type
3.3.2 By indication
3.3.3 By type of delivery
3.3.4 By packaging
3.3.5 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Patent landscape, 2022
3.9.1 Top 10 patented lyophilized injectable drugs
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company positioning matrix
4.4 Competitive analysis of major market players
4.5 Strategic outlook matrix
4.6 Strategy dashboard, 2022
Chapter 5 Lyophilized Injectable Drugs Market Size and Forecast, By Drug type (USD Million)
5.1 Key trends, by drug type
5.2 Anti-infectives
5.3 Anti-neoplastics
5.4 Anticoagulants
5.5 Hormones
5.6 Antiarrhythmics
5.7 Other drug types
Chapter 6 Lyophilized Injectable Drugs Market Size and Forecast, By Indication (USD Million)
6.1 Key trends, by indication
6.2 Autoimmune diseases
6.3 Respiratory diseases
6.4 Gastrointestinal disorders
6.5 Oncology
6.6 Cardiovascular diseases
6.7 Infectious diseases
6.8 Metabolic disorders
6.9 Other indications
Chapter 7 Lyophilized Injectable Drugs Market Size and Forecast, By Type of Delivery (USD Million)
7.1 Key trends, by type of delivery
7.2 Prefilled diluent syringes
7.3 Multi-step devices
Chapter 8 Lyophilized Injectable Drugs Market Size and Forecast, By Packaging (USD Million)
8.1 Key trends, by packaging
8.2 Vials
8.3 Cartridges
8.4 Prefilled devices
Chapter 9 Lyophilized Injectable Drugs Market Size and Forecast, By Distribution Channel (USD Million)
9.1 Key trends, by distribution channel
9.2 Hospital pharmacy
9.3 Retail pharmacy
9.4 Online pharmacy
Chapter 10 Lyophilized Injectable Drugs Market Size and Forecast, By Region (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Belgium
10.3.7 Netherlands
10.3.8 Norway
10.3.9 Switzerland
10.3.10 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Indonesia
10.4.7 New Zealand
10.4.8 Singapore
10.4.9 Thailand
10.4.10 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Chile
10.5.5 Colombia
10.5.6 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Egypt
10.6.5 Iran
10.6.6 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Bristol Myers Squibb
11.2 Gilead Sciences, Inc.
11.3 Cipla Limited
11.4 F. Hoffmann-La Roche Ltd.
11.5 Novo Nordisk A/S
11.6 Sanofi
11.7 Aurobindo Pharmaceuticals
11.8 Fresenius SE & Co. KGaA (Fresenius Kabi)
11.9 Merck & Co., Inc
11.10 Zydus Group
11.11 Vetter Pharma
11.12 Takeda Pharmaceutical Company Limited
11.13 Johnson & Johnson Services, Inc.
